Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

Kernan, Walter N., Viscoli, Catherine M., Furie, Karen L., Young, Lawrence H., Inzucchi, Silvio E., Gorman, Mark, Guarino, Peter D., Lovejoy, Anne M. +19 more·2016·New England Journal of Medicine
DOI 10.1056/nejmoa1506930

Cited by (1,110)

Items 901–1,000 of 1,110

  1. Response by Young et al to Letters Regarding Article, “Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus”
    Lawrence H. Young, Catherine M. Viscoli, Silvio E. Inzucchi, Walter N. Kernan · 2017 · Circulation
  2. Keeping Faith With Patients After Stroke or Transient Ischemic Attack
    Walter N. Kernan · 2018 · JAMA Neurology
  3. GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS FOR TYPE 2 DIABETES: A COMPREHENSIVE REVIEW OF HOW TO WEIGH THE OPTIONS, SELECT THE RIGHT PATIENTS, AND MAXIMIZE BENEFITS
    Lawrence Blonde, Vivian Andrew Fonseca · 2018 · Endocrine Practice
  4. Goals of Therapy
    Mikhail Kosiborod, Suzanne V. Arnold · 2017 · Elsevier eBooks
  5. Mechanisms of cardiovascular protection of non-insulin antidiabetic medications
    Angelo Avogaro · 2018 · Diabetes Mellitus
  6. Correlation of Glycosylated Hemoglobin And Oral Glucose Tolerance Test Results In Hyperinsulinemic Pre-Impaired Glucose Tolerance State Versus Normoinsulinemic-Normal OGTT
    Pilar D Torres-Salvador, Gelinemae G Malaza, LEILANI BASA MERCADO-ASIS · 2018 · Journal of Medicine University of Santo Tomas
  7. Diabetes and stroke
    Jennifer Kirsty Burton, Terence J. Quinn, Miles Fisher · 2019 · Practical Diabetes
  8. Positionspapier zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (pAVK) bei Menschen mit Diabetes mellitus – Gemeinsame Stellungnahme der Deutschen Diabetes Gesellschaft (DDG), der Deutschen Gesellschaft für Angiologie (DGA) sowie der Deutschen Gesellschaft für Interventionelle Radiologie (DeGIR)
    Bernd M. Balletshofer, Wulf D. Ito, Holger Lawall, Nasser M. Malyar, Yves Oberländer, Peter Reimer, Kilian Rittig, Markus Zähringer · 2019 · Diabetologie und Stoffwechsel
  9. Noninsulin Therapy for Diabetes
    Rebecca Maxson, Emily K. McCoy · 2020 · Physician Assistant Clinics
  10. Prevention of type 2 diabetes in patients with chronic heart failure
    Е.П. Павликова, A. G. Sorokina, A. V. Potapenko · 2020 · Clinical pharmacology and therapy
  11. Peroxisome proliferator-activated receptor agonists and reversal of vascular degeneration through DNA repair, a step toward drug-induced regenerative medicine
    Peter Afdal, Habiba‐Allah Ismail, Mirette Ashraf, Nada Hafez, Nardine Nasry, Nouran Hafez, Nourhan Hatem Youssef, Nourhan Samy, Rana Saeed, Antoine Fakhry AbdelMassih · 2020 · Cardiovascular Endocrinology & Metabolism
  12. Hígado graso no alcohólico: certezas e incertidumbres de una epidemia silenciosa
    Esteban González Ballerga, Andrea Curia, Kenneth J. Cusi · 2020 · Acta gastroenteorológica latinoamericana/Acta gastroenterológica latinoamericana
  13. DIABETES MELLITUS AND COVID-19. FEATURES OF THE MUTUAL INFLUENCE OF THE TWO PANDEMICS
    JULIYA S. KOVALENKO, Ivanova La, Король Инна Владимировна, TAMILA V. BIZHEVA · 2021 · The Bulletin of Contemporary Clinical Medicine
  14. Stroke in Patients with Diabetes: Is It Time to Expand Public Health Priority to Encompass High-Risk Patients with Increased Insulin Resistance?
    Sian Bradley, Francis Muttamthottil Varghese, Bindu Menon, Man Mohan Mehndiratta, Sonu M. M. Bhaskar · 2021 · EMJ Diabetes
  15. New Therapeutic Agents in Obesity-Related Cardiovascular Disorders: Molecular and Cellular Insights
    Belma Turan, Deniz Billur · 2021 · Advances in biochemistry in health and disease
  16. Diabetes Mellitus
    Nadine El Asmar, Baha M. Arafah, Charles Kent Smith · 2022 · Springer eBooks
  17. Outpatient Management of Type 2 Diabetes Mellitus
    Donna Lee, Joel Zonszein · 2022 · Springer eBooks
  18. Neuroprotection in Cerebrovascular Disease
    Kewal K. Jain · 2019 · Springer protocols handbooks/Springer protocols
  19. Portuguese Society for the Study of Obesity / Recommendations on Nutritional and Pharmacological Management of Diabetes After Bariatric Surgery
    Marta Alves, Carla A. Pedrosa, Cláudia Freitas, Gustavo Rocha, Isabel Albuquerque, João Duarte, Luı́s Cardoso, Raquel Carvalho, Sandra Belo, Teresa Azevedo et al. · 2019 · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo
  20. Positionspapier zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (pAVK) bei Menschen mit Diabetes mellitus
    Bernd M. Balletshofer, Dittmar Böckler, die DGG, Holger Diener, Jörg Heckenkamp, Wulf D. Ito, Marcus Katoh, Holger Lawall, die DGA, Nasser M. Malyar et al. · 2021 · Der Diabetologe
  21. Stroke prevention – review of the latest reports
    Radosław Kasperski, Małgorzata Piekarska, Katarzyna PACEK · 2023 · Journal of Education Health and Sport
  22. Systemic benefits of Gc inhibition to preserve insulin sensitivity
    Taiyi Kuo, Domenico Accili · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Perfil clínico e farmacoterapêutico das pessoas com diabetes mellitus tipo 2 em uma unidade de saúde militar do estado de São Paulo
    André Henrique Freitas de Braga e Bessa · 2023
  24. Bone and Rheumatic Disorders in Diabetes
    Andrew B. Grey, Nicola Dalbeth · 2024 · Wiley eBooks
  25. Oral Glucose‐Lowering Agents
    Clifford J. Bailey, Andrew J. Krentz · 2024
  26. Latest clinical research
    Mark Greener · 2017 · Independent Nurse
  27. Pioglitazone reduces risk of stroke or MI
    Karina Huynh · 2016 · Nature Reviews Cardiology
  28. Wie effektiv sind aktuelle Präventions- und Therapiestrategien bei Schlaganfall?
    Hans‐Christoph Diener, Christian P Gerloff · 2016 · InFo Neurologie + Psychiatrie
  29. Ein Glitazon kann ein erneutes vaskuläres Ereignis verhindern
    Hans‐Christoph Diener · 2016 · InFo Neurologie + Psychiatrie
  30. Insulin sensitivity is a Rubik’s Cube
    Kenneth H. Gabbay · 2016 · American Journal of Clinical Nutrition
  31. Authors’ reply to Gallagher and Winocour
    Laurent Azoulay, Kristian B. Filion · 2016 · BMJ
  32. Don’t dismiss pioglitazone on basis of uncertain risk
    Alison Gallagher, Peter H. Winocour · 2016 · BMJ
  33. Cerebrovascular Anatomy, Neuropathology, Clinics of Stroke: Endovascular Treatment, Decompressive Craniectomy
    Erion K. Musabelliu, Masahiro Oomura, Yoko Kato · 2016 · InTech eBooks
  34. Diabetes medications improve cardiovascular outcomes: the paradigm shifts
    Kenneth J. Cusi · 2016 · Current Opinion in Lipidology
  35. Antihyperglycemic Medications
    Karen A. Beer · 2016 · Physician Assistant Clinics
  36. LEADER-Studie: 22 %ige Senkung der kardiovaskulären Mortalität
    Irfan Vardarli, Cemil Özcelik · 2016 · Der Kardiologe
  37. Polarization of Microglia/Macrophages in Brain Ischaemia: Relevance for Stroke Therapy
    Diana Amantea, Rosaria Greco, Cristina Tassorelli, Giacinto Bagetta · 2017 · Springer series in translational stroke research
  38. Pioglitazone: Good news for diabetic patients with stroke?
    Luis Castilla‐Guerra, María del Carmen Fernández‐Moreno, Miguel Angel Colmero-Camacho · 2017 · European Journal of Internal Medicine
  39. Lessons from Recent Cardiovascular Outcome Trials of Type 2 Diabetes
    Nam Hoon Kim, Sin Gon Kim · 2017 · Journal of Korean Diabetes
  40. Hypothèses mécanistiques pouvant expliquer les effets cardiovasculaires observés avec les inhibiteurs de SGLT2 et les agonistes des récepteurs du GLP-1
    Bruno L Vergès · 2017 · Médecine des Maladies Métaboliques
  41. A robust method to estimate regional polygenic correlation identifies heterogeneity in the shared heritability between complex traits
    Guillaume Paré, Shihong Mao, Wei Q. Deng · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  42. Consequence of Energy Imbalance in Prostate Cancer and Comorbidities
    Jeannette M. Schenk, Jonathan Lawrence Wright · 2017 · Energy balance and cancer
  43. Which Patients With Ischemic Stroke and Insulin Resistance May Benefit From Pioglitazone Hydrochloride?
    Graeme J. Hankey · 2017 · JAMA Neurology
  44. Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes
    Kenneth J. Cusi · 2017 · Contemporary diabetes
  45. Surveys of the Galactic center and the nature of the Galactic center lobe
    Casey J. Law · 2007 · arXiv (Cornell University)
  46. The Current Role of Glucose Control Medications in Primary and Secondary Prevention for Cardiovascular Disease
    Joao Lucas O Connell · 2017 · MOJ Gerontology & Geriatrics
  47. Neues beim Schlaganfall
    Hans‐Christoph Diener, Martin Dichgans, Benedikt Frank · 2018 · Neuroradiologie Scan
  48. Az antidiabetikumok kardiovaszkuláris szerepe a véletlen besorolásos vizsgálatokban és az újabb ajánlások világában
    László Bajnok · 2017 · Cardiologia Hungarica
  49. Treatment with Oral Drugs
    Cristina Bianchi, Giuseppe Daniele, Angela Dardano, Stefano Del Prato · 2018 · Endocrinology
  50. Oral diabetes treatments and cardiovascular disease
    Pierre‐Jean Saulnier, Samy Hadjadj · 2018
  51. Management of Diabetes and/or Hyperglycemia in Acute Coronary Syndrome, Acute Stroke, and Acute Heart Failure
    Miles Fisher · 2018
  52. The year in cardiology 2017: prevention
    Børge Grønne Nordestgaard, Francesco Cosentino, Ulf Landmesser, Ulrich Laufs · 2018 · Cardiologia Croatica
  53. Cardiovascular outcome trials in diabetes: what have we learnt?
    Mike G. Kirby, Nick Boon · 2018 · Trends in Urology & Men s Health
  54. Pharmacological Intervention for the Prevention of Diabetes Mellitus
    Han Na Joung, Hyuk‐Sang Kwon · 2018 · Journal of Korean Diabetes
  55. Fall 57: 73 Jahre, ♂, DM Typ 2, Übergewicht, Apoplex Prävention
    Jan Gröner · 2018 · Springer eBooks
  56. Tackling Cardiovascular Risk in Type 2 Diabetes: Does Baseline Glucose Control Matter?
    Stephen James Nicholls, Alex D. H. Brown · 2018 · EClinicalMedicine
  57. Research roundup: April 2016
    Mark Greener · 2016 · Nurse Prescribing
  58. Pioglitazone May Lower Risk for Recurrent Stroke in Prediabetic Stroke Patients
    Susan F. FitzGerald · 2019 · Neurology Today
  59. Secondary stroke prevention in patients with type 2 diabetes. Is time for more specific recommendations?
    Luis Castilla‐Guerra, María del Carmen Fernández‐Moreno, Jose Antonio Pérez de León · 2019 · Diabetes Research and Clinical Practice
  60. Diabetes and Stroke: The Role of Glucose Regulation
    Forrest J. Lowe, Wuwei Feng · 2019 · Springer eBooks
  61. ¿Ha cambiado el paradigma de la prevención del ictus en los pacientes con diabetes?
    Luis Castilla‐Guerra, María del Carmen Fernández‐Moreno, M. A. Colmenero Camacho · 2019 · Atención Primaria
  62. Response to Letter to the Editor: “Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care”
    Olga Vaccaro, Antonio Nicolucci, Giuseppe Lucisano, Maria Masulli, Gabriele Riccardi · 2020 · The Journal of Clinical Endocrinology & Metabolism
  63. Manage cardiovascular risk in patients with type 2 diabetes by using agents with proven cardiovascular benefits
    Adis Medical Writers · 2020 · Drugs & Therapy Perspectives
  64. Paradigm shift in the management of DM & CVD —preventing the next CV event
    Yehuda Handelsman, Zachary T. Bloomgarden · 2020 · Journal of Diabetes
  65. Risikofaktoren und Primärprävention
    Karim Hajjar · 2020 · Elsevier eBooks
  66. NAFLD and Cardiovascular and Cardiac Disease: Clinical Implications
    Eleonora Scorletti, Christopher D. Byrne · 2020 · Springer eBooks
  67. Secondary Stroke Prevention and Management for the Neuro-Ophthalmologist
    Line Abdul Rahman, Ashley Wabnitz, Tanya N. Turan · 2020 · Journal of Neuro-Ophthalmology
  68. Benefit Class of Second-line Anti-diabetic Medication on Types of Dementia in Type 2 Diabetes: A Nationwide Real-world Longitudinal Study
    Won Jun Kim, Jung Hyun Noh, Kyungdo Han, Cheol‐Young Park · 2020 · Research Square
  69. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus
    Silvio E. Inzucchi, Mikhail Kosiborod · 2017 · Annals of Internal Medicine
  70. Perspektiven präventiver Therapie wider Schlaganfall und Demenz
    Sebastian Jander · 2021 · Info Diabetologie
  71. Jak postupovat v boji s inzulinovou rezistencí u pacientů s DM 2. typu
    Martin Haluzı́k · 2020 · Vnitřní lékařství
  72. Komentář k článku: Co může internista udělat pro svého pacienta po ischemické cévní mozkové příhodě Vnitř Lek 2021; 67(1): 7-14 Co může diabetolog udělat pro svého pacienta po iCMP?
    Jan Brož, Jana Malinovská, Barbora Pelechová · 2021 · Vnitřní lékařství
  73. Arterial Calcification and Cerebral Disease: Stroke and Dementia
    Fisnik Jashari, Per Olov Wester, Michael Y. Henein · 2021 · Springer eBooks
  74. Ischemic Stroke Etiology and Secondary Prevention
    Mary Carter Denny, Ahmad Riad Ramadan, Sean Isaac Savitz · 2019 · Cambridge University Press eBooks
  75. Anestesia y diabetes en el perioperatorio
    Angélica Yanine López Ramírez, Norma Elizabeth Carrillo Molina, Jaime Pablo Antonio Ortega García · 2021 · Anales Médicos de la Asociación Médica del Centro Médico ABC
  76. Long-Term Glycemic Control for Stroke Survivors
    Dong-Wan Kang · 2021 · Stroke revisited
  77. Consensus 2021 for medical management of type 2 diabetes from the diabetes, obesity, and nutrition working group of the Spanish Society of Internal Medicine
    Francisco Javier Carrasco-Sánchez, Jos� M. Fern�ndez-Rodr�guez, Pedro Pablo Casado Escribano, Jos� P. Miramontes-Gonz�lez, Ricardo G�mez-Huelgas, Mar�a D. Garc�a-de-Lucas, Javier Ena, Juana Carretero-G�mez · 2021 · Spanish Journal of Medicine
  78. Glucose-Lowering and the Risk of Cardiovascular Events with Novel Antidiabetic Therapies: A Systematic Review and Additive-effects Network Meta-Analysis
    Luiz Sérgio Fernandes de Carvalho, Ana Cláudia Cavalcante Nogueira, Riobaldo M.R. Cintra, Isabella Bonilha, Beatriz Luchiari, Alexander Koglin Benchimol, Carlos Eduardo Barra Couri, Jairo Lins Borges, Joaquim Barreto, Andrei Carvalho Sposito · 2021 · Research Square
  79. Standard Pharmacological Treatment of Diabetes Based on the Guidelines
    Jun Sung Moon, Kyu Chang Won · 2021 · Stroke revisited
  80. Choosing Medications for Type 2 Diabetes – What Weighting Should Be Given to Cardiovascular Risk Reduction?
    Adrian V Vella · 2021 · Wiley eBooks
  81. Evolution in Understanding of Cardiovascular Outcomes in Diabetes
    Anuj Maheshwari · 2021 · Journal of Diabetes Mellitus
  82. Epigenetics in precision medicine of cardiovascular disease
    Lucía Pinilla, Ferrán Barbé, María José Guerra Palmero · 2021 · Elsevier eBooks
  83. Progettazione urbana e pianificazione in condizioni nuove: trasformazioni urbane a Amsterdam, Rotterdam e L'Aia
    Han Meyer, Willem Hermans, John Westrik · 1997 · Zodiac
  84. Stroke
    Yuming Xu, Bo Song, Hui Fang, Lulu Pei · 2021 · Springer eBooks
  85. COVID-19 ANOSMIA AND LACUNAR STROKE.
    Humberto Foyaca-Sibat, Lourdes de Fátima Ibañez Valdés · 2021 · Research Square
  86. Role of High VWF and Low ADAMTS-13 in Ischemic Stroke
    Atiqa Arshad, M. Rizwan Gohar, Aafrinish Amanat · 2022 · Pakistan Journal of Medical and Health Sciences
  87. The 5th Annual Heart in Diabetes Conference (part 2)
    Zachary T. Bloomgarden · 2022 · Journal of Diabetes
  88. Risk Factors
    Gary K. K. Lau, Sarah Tamsin Pendlebury, Peter Malcolm Rothwell · 2018 · Cambridge University Press eBooks
  89. Treatment with Oral Drugs
    Cristina Bianchi, Giuseppe Daniele, Angela Dardano, Stefano Del Prato · 2018 · Endocrinology
  90. Bone and Rheumatic Disorders in Diabetes
    Andrew B. Grey, Nicola Dalbeth · 2016 · Wiley eBooks
  91. Stroke
    Yuming Xu, Bo Song, Hui Fang, Lulu Pei · 2020 · Springer eBooks
  92. Type 2 diabetes: glycaemic control
    David Levy MD FRCP · 2017 · Wiley eBooks
  93. Unwinding Link between Coronavirus and Diabetes Patient
    Shailendra Singh Bhadauria, Rishabha Malviya, Pramod Kumar Sharma · 2022 · Endocrine Metabolic & Immune Disorders - Drug Targets
  94. Perspektiven präventiver Therapie wider Schlaganfall und Demenz
    Sebastian Jander · 2022 · CME
  95. The Risk of Carotid Plaque Instability in Patients with Metabolic Syndrome: It is Higher in Women with Hypertriglyceridemia
    Francesca Servadei, Lucia Anemona, Marina Cardellini, Manuel Scimeca, Manuela Montanaro, Valentina Rovella, Francesca Di Daniele, Erica Giacobbi, Jacopo M. Legramante, Annalisa Noce et al. · 2021 · Research Square
  96. Scientific surgery
    2016 · British journal of surgery
  97. Diabetes Mellitus
    Harsh V Thakkar, K. Negishi · 2021 · Diastology
  98. Diabetes und Zentralnervensystem
    Frank Joachim Erbguth · 2017 · Der Diabetologe
  99. Diabetes Mellitus
    Nadine El Asmar, Baha M. Arafah, Charles Kent Smith · 2020 · Springer eBooks
  100. Medical Therapies
    Gary K. K. Lau, Sarah Tamsin Pendlebury, Peter Malcolm Rothwell · 2018 · Cambridge University Press eBooks